āĻšā§āĻŽALC âĸ SWX
add
Alcon AG
ā§Ŧā§Š.ā§ā§¨Â CHF
ā§Ž āĻāĻžāύā§, ⧍:ā§Ē⧍:ā§Ģ⧝ PM GMT +ā§§ · CHF · SWX · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āϏā§āĻāĻCH-āĻ āϤāĻžāϞāĻŋāĻāĻžāĻā§āĻā§āϤ āϏāĻŋāĻāĻŋāĻāϰāĻŋāĻāĻŋCH-āĻ āĻšā§āĻĄāĻā§ā§āĻžāϰā§āĻāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§Ŧā§Ē.ā§Ŧā§ĒÂ CHF
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§Ŧā§Š.ā§Ģā§¨Â CHF - ā§Ŧā§Ē.ā§Ēā§Ŧ CHF
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§Ģā§.ā§Ŧā§ŽÂ CHF - ā§Žā§.ā§Ļā§ĻÂ CHF
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§Š.ā§§ā§ŽāĻļāĻ¤Â āĻā§ CHF
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§§ā§§.ā§Šā§Ē āϞāĻž
P/E āĻ
āύā§āĻĒāĻžāϤ
ā§Šā§Ž.ā§Ļā§Ē
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
ā§Ļ.ā§Ēā§Ē%
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
SWX
āĻāĻŦāϰ⧠āϰā§ā§āĻā§
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
| (USD) | āϏā§āĻĒ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ⧍ā§Ŧā§§.ā§Ēā§Ļ āĻā§ | ā§Ŧ.ā§Ģ⧍% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ⧧⧧⧍.⧍ā§Ļ āĻā§ | ā§.⧝⧝% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§¨ā§Š.ā§ā§Ļ āĻā§ | -⧝.ā§Žā§¯% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ⧝.ā§Ļā§ | -ā§§ā§Ģ.ā§Šā§¯% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | ā§Ļ.ā§ā§¯ | -⧍.ā§Ēā§% |
EBITDA | ā§ā§Ž.ā§Ēā§Ļ āĻā§ | ⧍ā§Ŧ.ā§Ēā§Ģ% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ā§§ā§Ŧ.⧍ā§Ģ% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (USD) | āϏā§āĻĒ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§§ā§Ē⧝.⧝ā§Ļ āĻā§ | -⧧⧍.ā§ā§Ģ% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§Š.ā§§ā§ĢāĻļāĻ¤Â āĻā§ | ā§Š.ā§Žā§Š% |
āĻŽā§āĻ āĻĻāĻžā§ | ⧝ā§Ēā§Š.ā§Ŧā§Ļ āĻā§ | ā§Ģ.ā§§ā§Ŧ% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ⧍.⧍⧧āĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ā§Ē⧝.ā§§ā§¨Â āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§§.ā§Ēā§Ē | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ⧍.ā§Ŧā§% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§Š.ā§Ļā§% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
| (USD) | āϏā§āĻĒ ā§¨ā§Ļ⧍ā§Ģinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
|---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ā§¨ā§Š.ā§ā§Ļ āĻā§ | -⧝.ā§Žā§¯% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | ā§ā§¨.ā§Ēā§Ļ āĻā§ | -ā§Š.ā§Ļā§Ž% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Šā§§.⧍ā§Ļ āĻā§ | ā§Šā§Ģ.ā§Ēā§Ļ% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§Šā§§.ā§Ļā§Ļ āĻā§ | -ā§¨ā§Žā§¨.ā§ā§¨% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | ⧝.ā§Ļā§Ļ āĻā§ | -ā§Ģā§Š.ā§Ŧā§§% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| ā§Ģ⧝.ā§ā§§Â āĻā§ | ā§Šā§§.⧍ā§% |
āϏāĻŽā§āĻĒāϰā§āĻā§
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
⧧⧝ā§Ēā§Ģ
āϏāĻĻāϰ āĻĻāĻĒā§āϤāϰ
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
⧍ā§Ģ,ā§Ļā§Ļā§Ļ